LFVN Q1'27 Earnings: EPS estimate is 0.06 USD

Lifevantage Corporation (LFVN) will report Q1'27 earnings on November 9. Analysts expect revenue of $40.49M and EPS of $0.06. Results will be released after market close at 4:00 PM ET.

Original reporting
Published Nov 6, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 12:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LFVN Q1'27 Earnings: EPS estimate is 0.06 USD — source image
Decision brief

The 30-second read

$LFVNNeutralLow
01

Why it matters

The preview provides the first public estimate of Q1'27 performance, which may shape pre‑earnings positioning.

02

Market read

The article offers a modest earnings preview for a micro‑cap, with limited broader market relevance.

03

What to watch

Potential upcoming product launches or regulatory approvals not reflected in the current estimate.

Relevance 5/10Novelty 5/10Timing: pre‑market before earnings release on Nov 9

Background

Lifevantage Corp (LFVN) is a micro‑cap health‑supplement company that reports quarterly results on a regular schedule.

Company-level read

Ticker impact

$LFVNNeutralMedium confidence
Context

Article previews LFVN Q1'27 earnings with revenue and EPS estimates before the official release.

Expected impact

limited movement expected as the guidance is modest and market may price in a small beat or miss.

Evidence & confidence

Guidance is low‑key and the company is micro‑cap; any surprise will likely cause only modest price swings.

Market effects

Minimal impact on the broader health‑supplement sector.

Limited to U.S. micro‑cap investors.

Low

Counterpoint

If the market underestimates LFVN's growth potential, the modest guidance could be a buying opportunity.

Key entities

  • Lifevantage Corp

    Issuer of the earnings preview.

Related articles

$LFVNMed

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Lifevantage Corp (LFVN) filed an SEC Form 8-K — Results of Operations and Financial Condition. LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026 Salt Lake City, UT, August 27, 2026 , LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the c

$AAONHighAI 8/10

AAON (AAON) Raised Its Full Year Outlook After Record Q3

AAON (AAON) reported record Q3 2026 results with sales of $707.43M, up from $384.24M a year earlier, and raised its full-year outlook to 72-75% growth. The company restated prior financials due to internal control issues, which it claims have been corrected. The update reflects stronger operational performance and momentum in its data center cooling business.

$CEGHighAI 8/10

Constellation CEO Sounds the Alarm: Data Center Demand Was a “Massive Overestimation.” Its Nuclear Contracts Run to the 2040s

Constellation Energy CEO Joe Dominguez stated that data center demand was overestimated, impacting grid projects. The company raised 2026 EPS guidance to $12.50-$12.80. Analysts expect EPS to rise from $9.39 in 2025 to $16.80 in 2028. Constellation has secured long-term contracts, including deals with Google and Amazon, mitigating demand risks.